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trains. Results of antimicrobial synergy testing indicate that
lthough certain combinations may act synergistically, it was
till strain dependent. These preliminary ﬁndings require
urther conﬁrmation with testing of a larger number of iso-
ates. This study was funded by the University of Malaya
esearch Grant F vote: FS242/2008B
oi:10.1016/j.ijid.2010.02.1579
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Background: Describe susceptibility proﬁle of KPC Kleb-
iella pneumoniae producers recovered in a teaching
ospital from São Paulo.
Methods: We analyzed 27 isolates of KPC, one per
atient, from July 2008 to April 2009. Identiﬁcation was per-
ormed by GNI650 Cards VitekTM (Biomerieux, Marcy l’Etoile,
rance); susceptibility test was performed by disk diffusion
nd the Hodge Test was done according to CLSI-M100S19
ecommendations. blaKPC detection was done by PCR with
reviously described primers and Pulsed Field Gel Elec-
rophoresis (PFGE) was also performed. Minimal Inhibitory
oncentration (MIC) for polymyxin B, tigecycline and car-
apenens was performed by EtestTM (Biomerieux, Marcy
’Etoile, France).
Results: KPC antibiogram showed multiple resistance as
xpected: 100% to ertapenem, 81,4% to meropenem, 77,7%
o imipenem, 93,6% to amikacin; 82,5% to gentamicin, 89%
o cefepime and ceftazidime and 100% to ciproﬂoxacin, sul-
hametoxazol/trimetropim, piperacillin/tazobactam and to
ztreonam. MIC 50/90 were 2mg/l and 3mg/l to tigecyclin,
nd 2mg/l and 48mg/l to polymyxin B. PFGE showed that
9% belonged to the same molecular proﬁle.
Conclusion: KPC isolates showed very few therapeutically
ptions being tygecyclin the most active drug among those
solates. In our institution treatment with polymyxin B alone
as to be carefully monitored until MIC is available. The
ame molecular proﬁle emphasizes the horizontal spreading
f these multiresistant bacteria.
oi:10.1016/j.ijid.2010.02.1580
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Background: Emergence of carbapenem resistant enter-
bacteriaceae (CRE) is worrisome and polymyxins are
ossible therapeutic options. The objective of this article
o
w
h
pternational Congress on Infectious Diseases (ICID) Abstracts
s to describe emergency of polymyxins resistance during
herapy.
Methods: A 30 years old male patient with bilioma after
iver transplantation had eighteen successive cultures iso-
ates of E. aerogenes (Ea)from blood and peritoneum ﬂuid
ecovered during thirty days hospitalization. Identiﬁcation
as done by VitekTM (Biomerieux) and antimicrobial suscep-
ibility test were done by disk-diffusion (DD) and EtestTM (AB
iodisk) according to CLSI. Polymixins agar dilution was also
erformed. All isolates were submitted to pulsed ﬁeld gel
lectrophoresis analysis.
Results: In the third day of hospitalization the ﬁrst blood
ulture was positive for Ea susceptible to carbapenens. MIC
or polymyxin B was 1mg/L and for colistin 0,5mg/L. DD
howed 14mm of zone inhibition for colistin. After six days
f meropenem therapy Eaisolates became resistant to car-
apenens with MIC higher than 32mg/L. Colistin therapy
as initiated until patient’s death. The eight initials iso-
ates recovered before colistin treatment had MIC less than
g/ml for polymyxins and eight Ea isolates recovered after
his period had MIC above 12g/ml for polymyxins. The four-
eenth isolate, one day before the patient’s death, had MIC
f 64mg/L for polymyxin B and colistin, DD inhibition zone
or colistin was 7mm. Correlation between DD and MIC above
!g/ml for polymyxins was seen with disk inhibition zones
nferior than 13mm. All Ea belonged to the same clone.
Conclusion: CRE is a therapeutically and epidemiological
hallenge in every hospital. Colistin is one of the therapeu-
ically options but resistance may emerge during treatment
nd its in vitro activity is not routinely recommended by
LSI.
oi:10.1016/j.ijid.2010.02.1581
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Background: Acinetobacter baumannii is an increasingly
ommon nosocomial pathogen. Carbapenems have been
he agents of choice for severe Acinetobacter infections.
e describe an outbreak of multidrug-resistant (MDR) A.
aumannii that produced OXA-66 carbapenemase and was
esistant to imipenem. We also analyze the relationship
etween the spread of this strain and patients’ movements
ithin the hospital.
Methods: Thirty-one isolates of A. baumannii with very
imilar susceptibility patterns from 15 patients, recovered
n a 2 months period, were studied. We analyzed 8 more
solates recovered during the following year. ERIC-PCR and
APD genotyping methods were used to deﬁne clusters of
lonally related isolates. PFGE was used to conﬁrm the
esults and to check the maintenance of the epidemic strain
ver the following year. Patterns of possible transmission
ere analyzed by recording patient movements within the
ospitals. Antibiotic susceptibility testing to 28 agents was
erformed by microdilution and by E-test. The isolates were
